Rainbow Children’s Medicare Limited announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a consolidated annual profit of ₹2,815.44 million, driven by robust performance. Alongside these results, the Board has recommended a final dividend of ₹3.50 per share for the fiscal year 2025-26. The company also announced key leadership re-appointments and strategic initiatives, setting a positive outlook for the upcoming fiscal year.
Annual Financial Performance
For the financial year ended March 31, 2026, Rainbow Children’s Medicare achieved a consolidated revenue from operations of ₹17,030.77 million, compared to ₹15,158.66 million in the previous year. The consolidated net profit for the year stood at ₹2,815.44 million, reflecting substantial year-over-year growth from ₹2,442.27 million. The company’s standalone results mirrored this growth, with an annual profit of ₹2,500.16 million.
Dividend Recommendation
In a move to reward shareholders, the Board of Directors has recommended a final dividend of ₹3.50 per equity share (a 35% payout on a face value of ₹10 per share) for the fiscal year 2025-26. This dividend is subject to approval by shareholders at the upcoming 28th Annual General Meeting, which is scheduled to take place on July 29, 2026. The record date for the dividend eligibility has been set for July 21, 2026.
Leadership and Strategic Appointments
The company has strengthened its governance by approving the re-appointment of key leadership figures for a new five-year term, effective from August 11, 2026, to August 10, 2031. These include Dr. Ramesh Kancharla as Chairman and Managing Director and Dr. Dinesh Kumar Chirla as Whole Time Director. Additionally, the company extended the tenures of Independent Directors Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati, ensuring continuity in strategic oversight.
Operational Highlights
Strategic expansion remained a core focus during the year, highlighted by the acquisition of Prashanthi Medicare Private Limited and Pratiksha Women & Child Care Hospital Private Limited. These acquisitions have significantly contributed to the group’s revenue streams. Furthermore, the company successfully granted 267,550 stock options to eligible employees under its ESOP 2025 scheme, underscoring its commitment to talent retention and long-term organizational growth.
Source: BSE
